BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 31, 2026
Home » Authors » Kim Coghill

Kim Coghill

Articles

ARTICLES

House, Senate Pass Bioterrorism Bill On To Bush For Signature

May 28, 2002
By Kim Coghill

FDA Panel Votes In Favor Of Biogen's Amevive For Psoriasis

May 24, 2002
By Kim Coghill
SILVER SPRING, Md. - A panel of experts advising the FDA recommended approval of Biogen Inc.'s psoriasis drug Amevive on Thursday. (BioWorld Today)
Read More

FDA Panel Votes In Favor Of Biogen's Amevive For Psoriasis

May 24, 2002
By Kim Coghill
SILVER SPRING, Md. - A panel of experts advising the FDA recommended approval of Biogen Inc.'s psoriasis drug Amevive on Thursday. (BioWorld Today)
Read More

BIO Holds First Meeting On Biotechnology And The Law

May 22, 2002
By Kim Coghill

BIO Holds First Meeting On Biotechnology And The Law

May 22, 2002
By Kim Coghill

PDL Drops Development Of Zamyl After Phase III Failure

May 21, 2002
By Kim Coghill
Protein Design Labs Inc. decided against further development of Zamyl as an acute myeloid leukemia treatment on news that its Phase III trial failed to show statistical significance. (BioWorld Today)
Read More

PDL Drops Development Of Zamyl After Phase III Failure

May 21, 2002
By Kim Coghill
Protein Design Labs Inc. decided against further development of Zamyl as an acute myeloid leukemia treatment on news that its Phase III trial failed to show statistical significance. (BioWorld Today)
Read More

Variagenics Trims Staff, Programs To Focus On Cancer Diagnostics

May 20, 2002
By Kim Coghill

Variagenics Trims Staff, Programs To Focus On Cancer Diagnostics

May 20, 2002
By Kim Coghill

Manufacturing Snag Could Set NPS Back On Osteoporosis Drug

May 17, 2002
By Kim Coghill
View All Articles by Kim Coghill

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 30, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Brain with stroke illustration

    Brain-derived tau in blood predicts stroke severity and outcome

    BioWorld Science

    Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

  • Centessa’s CNT-9982 shows promise for MDD

    BioWorld Science
    Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
  • Red and blue bispecific antibodies

    First-in-class ADC targeting DEM-TXX shows high preclinical efficacy

    BioWorld Science
    Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing